Literature DB >> 21592927

Atrial angiosarcoma imaged by F-18 FDG PET/CT.

Ilknur Ak1, Oznur Dilek Ciftçi, Zeki Ustünel, Muammer Cumhur Sivrikoz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21592927     DOI: 10.5152/akd.2011.099

Source DB:  PubMed          Journal:  Anadolu Kardiyol Derg        ISSN: 1302-8723


× No keyword cloud information.
  6 in total

1.  The role of 2-[f-18] fluoro 2-deoxy d-glucose positron emission tomography in the preoperative staging of gastric cancer.

Authors:  Kazim Duman; Abdurrahman Simsek; Semih Gorgulu; Gokhan Yagci; Yusuf Peker
Journal:  Eurasian J Med       Date:  2013-10

2.  Molecular imaging of metastatic atrial angiosarcoma with positron emission tomography (PET) tracer 3'-deoxy-3'[(18)F]-fluorothymidine, [(18)F]-FLT imaging and early response evaluation.

Authors:  Kalevi Kairemo; Vivek Subbiah
Journal:  BMJ Case Rep       Date:  2019-05-06

3.  Role of 18F-FDG PET/CT imaging in cardiac and pericardial masses.

Authors:  Hongyan Yin; Wujian Mao; Hui Tan; Na Zhu; Quan Wan; Jing Shi; Lin Qiu; Yan Xiu; Rongkui Luo; Haojun Yu; Hongcheng Shi
Journal:  J Nucl Cardiol       Date:  2021-01-18       Impact factor: 3.872

4.  18F-FDG PET-CT for Evaluation of Cardiac Angiosarcoma: A Case Report and Review of Literature.

Authors:  Varun Singh Dhull; Punit Sharma; Anirban Mukherjee; Manisha Jana; Chandrasekhar Bal; Rakesh Kumar
Journal:  Mol Imaging Radionucl Ther       Date:  2015-02-05

5.  F-18 FDG PET/CT images of a rare primer cardiac tumour: Primary Pericardial Mesothelioma.

Authors:  İlknur Ak Sivrikoz; Hasan Önner; Emine Kasapoğlu Dündar; Yüksel Çavuşoğlu; Sadettin Dernek
Journal:  Anatol J Cardiol       Date:  2016-08       Impact factor: 1.596

6.  18F-FDG-PET/CT imaging in cardiac tumors: illustrative clinical cases and review of the literature.

Authors:  Maristella Saponara; Valentina Ambrosini; Margherita Nannini; Lidia Gatto; Annalisa Astolfi; Milena Urbini; Valentina Indio; Stefano Fanti; Maria Abbondanza Pantaleo
Journal:  Ther Adv Med Oncol       Date:  2018-08-30       Impact factor: 8.168

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.